UT Health Northeast in Tyler, TX, joins MD Anderson Network

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

UT Health Northeast in Tyler, TX, and MD Anderson Cancer Center announced a partnership to provide greater access to the most advanced cancer care available for adult patients in northeast Texas and the surrounding region.

Through the partnership, UT Health Northeast’s Cancer Treatment and Prevention Center joins MD Anderson Cancer Network, an international collaboration of hospitals and health systems that share and contribute to MD Anderson’s mission to end cancer. The center in Tyler will be known as UT Health Northeast MD Anderson Cancer Center when it officially launches in 2017.

UT Health Northeast’s cancer program will be clinically and operationally integrated with MD Anderson Cancer Center, joining only six other healthcare institutions across the U.S. and three facilities in Brazil, Spain and Turkey. Enhanced local access to MD Anderson’s multidisciplinary care, treatment innovations, standards of care and clinical trials will be hallmarks of the partnership.

The two organizations will join forces in the recruitment of all future program physicians and allied health staff. A national search to hire a medical director to lead the new program is planned.

YOU MAY BE INTERESTED IN

The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly for weight management, represents one of the most significant shifts in metabolic medicine in decades. With millions of people now using medications such as semaglutide and tirzepatide, we are witnessing a fundamental alteration in patient physiology that extends far beyond glucose control and weight loss. As these drugs approach 10% population penetrance in some demographics, the oncology community faces an urgent question: How will this metabolic transformation reshape cancer care?

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login